| Identification | Back Directory | [Name]
1H-Cyclopenta[b]pyridine-3-carboxamide, 2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)octahydro-N-[4-methyl-3-(trifluoromethyl)phenyl]-, (2R,3S,4aR,7aR)- | [CAS]
2761048-02-4 | [Synonyms]
C5aR-IN-1
Avacopan Impurity 8
1H-Cyclopenta[b]pyridine-3-carboxamide, 2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)octahydro-N-[4-methyl-3-(trifluoromethyl)phenyl]-, (2R,3S,4aR,7aR)- | [Molecular Formula]
C36H39F4N3O2 | [MOL File]
2761048-02-4.mol | [Molecular Weight]
621.71 |
| Hazard Information | Back Directory | [Uses]
C5aR-IN-1 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-1 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 47)[1]. | [References]
[1] Gonghua Pan, et al. Compounds as c5ar inhibitors. Patent WO2022028586A1. |
|
|